Home LiteratureArticle Details
PMID: 22014273 Published · epublish English Journal Article Research Support, Non-U.S. Gov't

Chromothripsis is a common mechanism driving genomic rearrangements in primary and metastatic colorectal cancer.

Genome biology ·Vol. 12 ·No. 10 ·2011-10-19 ·Pages R103

Kloosterman WP, Hoogstraat M, Paling O, Tavakoli-Yaraki M, Renkens I, Vermaat JS, van Roosmalen MJ, van Lieshout S, Nijman IJ, Roessingh W, van 't Slot R, van de Belt J, Guryev V, Koudijs M, Voest E, Cuppen E

Abstract

Structural rearrangements form a major class of somatic variation in cancer genomes. Local chromosome shattering, termed chromothripsis, is a mechanism proposed to be the cause of clustered chromosomal rearrangements and was recently described to occur in a small percentage of tumors. The significance of these clusters for tumor development or metastatic spread is largely unclear. We used genome-wide long mate-pair sequencing and SNP array profiling to reveal that chromothripsis is a widespread phenomenon in primary colorectal cancer and metastases. We find large and small chromothripsis events in nearly every colorectal tumor sample and show that several breakpoints of chromothripsis clusters and isolated rearrangements affect cancer genes, including NOTCH2, EXO1 and MLL3. We complemented the structural variation studies by sequencing the coding regions of a cancer exome in all colorectal tumor samples and found somatic mutations in 24 genes, including APC, KRAS, SMAD4 and PIK3CA. A pairwise comparison of somatic variations in primary and metastatic samples indicated that many chromothripsis clusters, isolated rearrangements and point mutations are exclusively present in either the primary tumor or the metastasis and may affect cancer genes in a lesion-specific manner. We conclude that chromothripsis is a prevalent mechanism driving structural rearrangements in colorectal cancer and show that a complex interplay between point mutations, simple copy number changes and chromothripsis events drive colorectal tumor development and metastasis.

MeSH Terms
Case-Control Studies Chromosome Aberrations Chromosomes, Human/genetics Colorectal Neoplasms/genetics,pathology Computational Biology DNA Repair Enzymes/genetics DNA, Neoplasm/analysis,genetics DNA-Binding Proteins/genetics Exodeoxyribonucleases/genetics Female Gene Dosage Gene Frequency Gene Rearrangement Genes, Neoplasm Humans Liver Neoplasms/genetics,secondary Male Point Mutation Polymorphism, Single Nucleotide Receptor, Notch2/genetics
Chemicals
DNA, Neoplasm DNA-Binding Proteins KMT2C protein, human NOTCH2 protein, human Receptor, Notch2 EXO1 protein, human Exodeoxyribonucleases DNA Repair Enzymes
Authors & Affiliations
16 authors, click to expand affiliations / ORCID
Kloosterman Wigard P
Department of Medical Genetics, University Medical Center Utrecht, Universiteitsweg 100, Utrecht, 3584 CG, The Netherlands.
Hoogstraat Marlous
Paling Oscar
Tavakoli-Yaraki Masoumeh
Renkens Ivo
Vermaat Joost S
van Roosmalen Markus J
van Lieshout Stef
Nijman Isaac J
Roessingh Wijnand
van 't Slot Ruben
van de Belt José
Guryev Victor
Koudijs Marco
Voest Emile
Cuppen Edwin
References (40)
40 references, click to expand
  1. Architectures of somatic genomic rearrangement in human cancer amplicons at sequence-level resolution.
    Genome Res. 2007 Sep;17(9):1296-303 PMID: 17675364
  2. Parallel progression of primary tumours and metastases.
    Nat Rev Cancer. 2009 Apr;9(4):302-12 PMID: 19308069
  3. Exploring the genomes of cancer cells: progress and promise.
    Science. 2011 Mar 25;331(6024):1553-8 PMID: 21436442
  4. Genome remodelling in a basal-like breast cancer metastasis and xenograft.
    Nature. 2010 Apr 15;464(7291):999-1005 PMID: 20393555
  5. Telomere dysfunction provokes regional amplification and deletion in cancer genomes.
    Cancer Cell. 2002 Aug;2(2):149-55 PMID: 12204535
  6. Massive genomic rearrangement acquired in a single catastrophic event during cancer development.
    Cell. 2011 Jan 7;144(1):27-40 PMID: 21215367
  7. High-resolution characterization of a hepatocellular carcinoma genome.
    Nat Genet. 2011 May;43(5):464-9 PMID: 21499249
  8. The genomic complexity of primary human prostate cancer.
    Nature. 2011 Feb 10;470(7333):214-20 PMID: 21307934
  9. PARK2 deletions occur frequently in sporadic colorectal cancer and accelerate adenoma development in Apc mutant mice.
    Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15145-50 PMID: 20696900
  10. Accurate SNP and mutation detection by targeted custom microarray-based genomic enrichment of short-fragment sequencing libraries.
    Nucleic Acids Res. 2010 Jun;38(10):e116 PMID: 20164091
  11. Mutational evolution in a lobular breast tumour profiled at single nucleotide resolution.
    Nature. 2009 Oct 8;461(7265):809-13 PMID: 19812674
  12. The patterns and dynamics of genomic instability in metastatic pancreatic cancer.
    Nature. 2010 Oct 28;467(7319):1109-13 PMID: 20981101
  13. The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.
    Annu Rev Biochem. 2010;79:181-211 PMID: 20192759
  14. Manifestation, mechanisms and mysteries of gene amplifications.
    Cancer Lett. 2006 Jan 28;232(1):79-89 PMID: 16288831
  15. Large common fragile site genes and cancer.
    Semin Cancer Biol. 2007 Feb;17(1):31-41 PMID: 17140807
  16. Fast and accurate short read alignment with Burrows-Wheeler transform.
    Bioinformatics. 2009 Jul 15;25(14):1754-60 PMID: 19451168
  17. Patterns of somatic mutation in human cancer genomes.
    Nature. 2007 Mar 8;446(7132):153-8 PMID: 17344846
  18. Chromothripsis identifies a rare and aggressive entity among newly diagnosed multiple myeloma patients.
    Blood. 2011 Jul 21;118(3):675-8 PMID: 21628407
  19. Complex landscapes of somatic rearrangement in human breast cancer genomes.
    Nature. 2009 Dec 24;462(7276):1005-10 PMID: 20033038
  20. Identification of somatically acquired rearrangements in cancer using genome-wide massively parallel paired-end sequencing.
    Nat Genet. 2008 Jun;40(6):722-9 PMID: 18438408
  21. Alternative end-joining is suppressed by the canonical NHEJ component Xrcc4-ligase IV during chromosomal translocation formation.
    Nat Struct Mol Biol. 2010 Apr;17(4):410-6 PMID: 20208544
  22. A census of amplified and overexpressed human cancer genes.
    Nat Rev Cancer. 2010 Jan;10(1):59-64 PMID: 20029424
  23. The consensus coding sequences of human breast and colorectal cancers.
    Science. 2006 Oct 13;314(5797):268-74 PMID: 16959974
  24. Chromothripsis as a mechanism driving complex de novo structural rearrangements in the germline.
    Hum Mol Genet. 2011 May 15;20(10):1916-24 PMID: 21349919
  25. Computational methods for discovering structural variation with next-generation sequencing.
    Nat Methods. 2009 Nov;6(11 Suppl):S13-20 PMID: 19844226
  26. Somatic mutations to CSMD1 in colorectal adenocarcinomas.
    Cancer Biol Ther. 2008 Apr;7(4):609-13 PMID: 18614856
  27. Mutation discovery by targeted genomic enrichment of multiplexed barcoded samples.
    Nat Methods. 2010 Nov;7(11):913-5 PMID: 20953175
  28. Comprehensive long-span paired-end-tag mapping reveals characteristic patterns of structural variations in epithelial cancer genomes.
    Genome Res. 2011 May;21(5):665-75 PMID: 21467267
  29. Circos: an information aesthetic for comparative genomics.
    Genome Res. 2009 Sep;19(9):1639-45 PMID: 19541911
  30. ArgBP2-dependent signaling regulates pancreatic cell migration, adhesion, and tumorigenicity.
    Cancer Res. 2008 Jun 15;68(12):4588-96 PMID: 18559503
  31. Telomeres and telomerase in cancer.
    Carcinogenesis. 2010 Jan;31(1):9-18 PMID: 19887512
  32. Comparative lesion sequencing provides insights into tumor evolution.
    Proc Natl Acad Sci U S A. 2008 Mar 18;105(11):4283-8 PMID: 18337506
  33. Common fragile site tumor suppressor genes and corresponding mouse models of cancer.
    J Biomed Biotechnol. 2011;2011:984505 PMID: 21318118
  34. Molecular origins of cancer: Molecular basis of colorectal cancer.
    N Engl J Med. 2009 Dec 17;361(25):2449-60 PMID: 20018966
  35. Development of personalized tumor biomarkers using massively parallel sequencing.
    Sci Transl Med. 2010 Feb 24;2(20):20ra14 PMID: 20371490
  36. Tumor progression in Apc(1638N) mice with Exo1 and Fen1 deficiencies.
    Oncogene. 2007 Sep 20;26(43):6297-306 PMID: 17452984
  37. The genomic landscapes of human breast and colorectal cancers.
    Science. 2007 Nov 16;318(5853):1108-13 PMID: 17932254
  38. Distant metastasis occurs late during the genetic evolution of pancreatic cancer.
    Nature. 2010 Oct 28;467(7319):1114-7 PMID: 20981102
  39. Genomics and the continuum of cancer care.
    N Engl J Med. 2011 Jan 27;364(4):340-50 PMID: 21268726
  40. Missense mutations in fumarate hydratase in multiple cutaneous and uterine leiomyomatosis and renal cell cancer.
    J Mol Diagn. 2005 Oct;7(4):437-43 PMID: 16237213
Article Info
Journal
Genome biology
Abbr.
Genome Biol
ISSN
1474-760X
Published
2011-10-19
Epub
2011-00-19
Pages
R103
Language
English
Region
England
NLM ID
100960660
PMCID
PMC3333773
Subset
IM
Databases
GEO
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]